DeepMed Research

VAPOTHERM, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1999-01-01

Employees: 251

Market Cap: -

Website: http://www.vapotherm.com

Clinical Trials

Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline

Not Applicable

Completed

Conditions: Breathlessness
Exercise
Muscle
Recovery
Dyspnea
Lactic Acidosis

Interventions: Device: High Velocity Therapy

First Posted Date: 2023-08-09

Last Posted Date: 2024-10-08

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 15

Registration Number: NCT05984186

Locations: 🇺🇸
Auburn University, Auburn, Alabama, United States

Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants

Not Applicable

Terminated

Conditions: Neonatal Respiratory Distress
Oxygen Saturation
Infant, Premature
Bronchopulmonary Dysplasia

Interventions: Device: Automated Control
Device: Manual Control

First Posted Date: 2021-09-01

Last Posted Date: 2024-06-26

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 15

Registration Number: NCT05030012

Locations: 🇺🇸
University of Utah Hospital, Salt Lake City, Utah, United States
🇺🇸
Children's National Hospital & Research Institute, Washington, District of Columbia, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

Clinical Stabilization of Hypercapnia: NIPPV v HVNI

Not Applicable

Completed

Conditions: Dyspnea
Hypercapnic Acidosis
Hypercapnic Respiratory Failure
Chronic Obstructive Pulmonary Disease

Interventions: Device: High Velocity Nasal Insufflation (HVNI)
Device: Noninvasive Positive Pressure Ventilation (NIPPV)

First Posted Date: 2021-01-14

Last Posted Date: 2024-08-09

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 68

Registration Number: NCT04709562

Locations: 🇺🇸
Valley Presbyterian Hospital, Los Angeles, California, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
George Washington University Hospital, Washington, District of Columbia, United States

and more 4 locations

Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Device Equivalence

Not Applicable

Terminated

Conditions: Hypercapnia
Respiratory Insufficiency
Dyspnea

Interventions: Device: Conventional Precision Flow
Device: HVNI HVT2.0 Device

First Posted Date: 2020-10-19

Last Posted Date: 2024-03-20

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 5

Registration Number: NCT04590014

Locations: 🇺🇸
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States

Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs

Not Applicable

Completed

Conditions: Hypercapnia
Dyspnea
Respiratory Insufficiency

Interventions: Device: Control Cannula - Unicorn Cannula - Prosoft Cannula
Device: Control Cannula - Prosoft Cannula - Unicorn Cannula

First Posted Date: 2020-08-14

Last Posted Date: 2024-02-23

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 26

Registration Number: NCT04512781

Locations: 🇺🇸
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States
🇺🇸
Erlanger Baroness Hospital, Chattanooga, Tennessee, United States

HVNI Ambulation Feasibility Study

Not Applicable

Completed

Conditions: Respiratory Insufficiency
Dyspnea

Interventions: Device: Precision Flow Plus
Device: Treatment as Usual

First Posted Date: 2019-03-22

Last Posted Date: 2020-10-19

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 32

Registration Number: NCT03885726

Locations: 🇺🇸
Midwest Chest Consultants, Saint Charles, Missouri, United States
🇺🇸
Knox Community Hospital, Mount Vernon, Ohio, United States
🇺🇸
Riverside Regional Medical Center, Newport News, Virginia, United States

High Flow Therapy for the Treatment of Respiratory Failure in the ED

Not Applicable

Completed

Conditions: Acute Respiratory Failure

Interventions: Device: Noninvasive positive pressure ventilation (NIPPV)
Device: Vapotherm

First Posted Date: 2014-09-10

Last Posted Date: 2019-05-23

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 204

Registration Number: NCT02236559

Locations: 🇺🇸
Athens Regional Medical Center, Athens, Georgia, United States
🇺🇸
Erlanger Health System, Chattanooga, Tennessee, United States
🇺🇸
Memorial Hermann Hospital, Houston, Texas, United States

and more 2 locations

IntellO2 vs Manual Control for Optimizing Oxygenation in Infants

Not Applicable

Completed

Conditions: Oxygen Titration in Preterm Infants to Manage Lung Disease

Interventions: Device: IntellO2
Other: Manual control

First Posted Date: 2014-02-28

Last Posted Date: 2018-06-27

Lead Sponsor: Vapotherm, Inc.

Target Recruit Count: 36

Registration Number: NCT02074774

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom
🇬🇧
Ashford and St. Peter's Hospitals NHS Trust, Chertsey, Surrey, United Kingdom

Non-Inferiority Trial of Acute HFT Versus nCPAP

Not Applicable

Withdrawn

Conditions: Mild-Moderate Obstructive Sleep Disordered Breathing

Interventions: Device: High-Flow Therapy
Device: Continuous Positive Airway Pressure

First Posted Date: 2013-05-22

Last Posted Date: 2023-05-03

Lead Sponsor: Vapotherm, Inc.

Registration Number: NCT01860560

Locations: 🇺🇸
Sleep Disorders Centers of the Mid-Atlantic, Glen Burnie, Maryland, United States

High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)

Not Applicable

Withdrawn

Conditions: Respiratory Insufficiency
Pulmonary Disease, Chronic Obstructive

Interventions: Device: Vapotherm High Flow Therapy
Device: Non-invasive positive pressure ventilation

First Posted Date: 2009-10-06

Last Posted Date: 2020-09-16

Lead Sponsor: Vapotherm, Inc.

Registration Number: NCT00990119

Locations: 🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy